Post by Will Bowler

Delighted to announce that today, Symprove was acquired by Metagenics LLC, a leading global provider of nutritional supplements headquartered in California. This marks an incredibly exciting new chapter for Symprove and marks a signicant step towards our mission of changing millions of lives globally. Thank you to our incredible investors and board members, bd-capital, whose support and guidance has been instrumental in the success of the business. During our partnership, the business has more than tripled in size, become the UK's no 1 probiotic (and the most recommended amongst healthcare practitioners) and has even been described as a "phenomenon in the wellness world" in the press.   More importantly, we've helped hundreds of thousands of people live healthier lives. Andy Dawson, Jamie Patmore, David Johnston, Richard Learwood (and before heading back to Aus, Rebecca Soulsby (née Schultz)) We set out last year to find our next partner and in Metagenics, we found the perfect one.  Metagenics share the same dedication to science, quality and their customers and will allow Symprove to go faster & further. For more about the transaction and both bd-capital & Metagenics, the press release is here: https://lnkd.in/ec66Smxz Massive thanks to all those who helped in what was an incredible global process. Jefferies: Brian Wood, Benjamin Williams, Jaidip Kumar, Alexander Klaphake, Alicia Sun, Edoardo Spaziani, Long Him Lui, Scott Bell Stephenson Harwood: Chris Manning, Malcolm MacDougall, Adrian Moss, Nicholas Stretch, Rajiv Kakkad, Harry House, Alex Aveyard,Luc Foley (and Thomas ("Jeff") Jefferson at Troutman) PwC: Lisa Hooker, Cameron Green, Tristram Bolton, Mike Seaton, Sharon Chakkar, Charlotte Angel, Oliver Lee OC&C: Claire Dannatt, Oliver Rowson, William Grover